Can-Fite BioPharma

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CANF and other ETFs, options, and stocks.

About CANF

Can-Fite BioPharma Ltd. is a biopharmaceutical company, which engages in the development of drugs for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. Its product pipeline include Piclidenoson, Namodenoson, and CF602.

CEO

Motti Farbstein

CEOMotti Farbstein

Employees

Employees5

Headquarters

Ramat Gan, HaMerkaz

HeadquartersRamat Gan, HaMerkaz

Founded

1994

Founded1994

Employees

Employees5

CANF Key Statistics

Market cap

13.88M

Market cap13.88M

Price-Earnings ratio

-0.36

Price-Earnings ratio-0.36

Dividend yield

—

Dividend yield—

Average volume

124.88K

Average volume124.88K

High today

$0.8253

High today$0.8253

Low today

$0.645

Low today$0.645

Open price

$0.6594

Open price$0.6594

Volume

671.05K

Volume671.05K

52 Week high

$3.12

52 Week high$3.12

52 Week low

$0.6301

52 Week low$0.6301

Can-Fite BioPharma

Why Robinhood?

Can-Fite BioPharma Ltd. is a biopharmaceutical company, which engages in the development of drugs for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. Its product pipeline include Piclidenoson, Namodenoson, and CF602. Show more

CANF Key Statistics

Can-Fite BioPharma Ltd. is a biopharmaceutical company, which engages in the development of drugs for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. Its product pipeline include Piclidenoson, Namodenoson, and CF602.